Abivax SA (ABVX) earnings
In the quarter ended December 2025, Abivax SA had revenue of 440,000 EUR, down 89.8% on a year earlier.
On September 21, 2026 it reported EPS of -1.71 against an estimate of -1.08 (missed).
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Last | Mon Sep 21, 2026 | — | -1.08 | -1.71 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 8 quarters from Abivax SA's 10-Q and 10-K filings with the SEC, in EUR. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Dec 31, 2025 | 440,000 EUR | -89.8% | — | — | -16283.9% | 2026-03-23 |
| Sep 30, 2025 | 2M EUR | +54.3% | -2.10 | — | -3950.7% | 2025-12-15 |
| Jun 30, 2025 | 1M EUR | -80.6% | -0.76 | — | -4254.0% | 2025-09-08 |
| Mar 31, 2025 | 994,000 EUR | -16.2% | -0.83 | — | -4748.5% | 2025-06-02 |
| Dec 31, 2024 | 4M EUR | — | — | — | -993.0% | 2025-03-24 |
| Sep 30, 2024 | 1M EUR | — | -0.87 | — | -3790.7% | 2025-12-15 |
| Jun 30, 2024 | 6M EUR | — | -0.62 | — | -627.7% | 2025-09-08 |
| Mar 31, 2024 | 1M EUR | — | -0.68 | — | -3766.5% | 2025-06-02 |
Questions
How did Abivax SA do last quarter?
In the quarter ended December 2025, Abivax SA had revenue of 440,000 EUR, down 89.8% on a year earlier.
From Abivax SA's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.